Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

This study has been completed.
Sponsor:
Collaborator:
Janssen Pharmaceutica
Information provided by (Responsible Party):
Harold W Koenigsberg, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT00158028
First received: September 8, 2005
Last updated: August 2, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2001
  Primary Completion Date: December 2001 (Final data collection date for primary outcome measure)
Publications: